Health

Chairman:  Joe Pitts (PA-16)
Jurisdiction: 
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Members

Republicans

Chairman: Joe Pitts (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Ed Whitfield (KY)
John Shimkus (IL)
Mike Rogers (MI)
Tim Murphy (PA)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Bill Cassidy (LA)
Brett Guthrie (KY)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)

Democrats

Ranking Member: Frank Pallone, Jr. (NJ)
John D. Dingell (MI)
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
Jim Matheson (UT)
Gene Green (TX)
G.K. Butterfield (NC)
John Barrow (GA)
Donna M. Christensen (VI)
Kathy Castor (FL)
John Sarbanes (MD)
Henry A. Waxman (CA)

January 27, 2014 | Press Release

Presidential Ally Moran on the State of Obamacare: “I don't think we're going to get enough young people signing up to make this bill work”

>>
January 23, 2014 | ICYMI

Health Law’s Uncertainty And Disastrous Rollout Raises More Concerns About Future of Health Care in America

Upton: “Moody’s latest downgrade is further evidence that the president’s health law is not the right prescription for reform.”

>>
January 22, 2014 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI), today led a group of House and Senate Republican lawmakers in sending a letter to Food and Drug Administration (FDA) Commissioner Margaret Hamburg expressing concerns about the FDA

>>
January 22, 2014 | Letter

Excerpt: We are writing to express grave concerns regarding a regulation … that would change longstanding policy regarding the 1984 Hatch-Waxman Act. The proposed regulation would allow generic manufacturers to alter an abbreviated new drug application (ANDA) label without the FDA’s prior approval.

>>
January 21, 2014 | Blog Post

With or Without Enrollment Figures as a Measure for Success, Health Law Continues to Fall Short  

>>
January 17, 2014 | Blog Post

UPTON: “Delaying the individual mandate was the right policy six months ago, and it is still the right policy today.”

>>

Pages